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doi:10.1016/j.jfma.2011.04.004Background/Purpose: Abnormal alanine aminotransferase level (ALT) levels might be associ-
ated with type 2 diabetes, but whether higher ALT levels within the normal range predict
the risk is unknown.
Methods: We followed a community-based cohort of 3446 individuals who were 35 years old
without diabetes and hepatitis B or C in southern Taiwan for 8 years (1997e2004) to study the
risk for type 2 diabetes with different normal ALT levels.
Results: Among the 337 incident diabetes cases, 16.0% were from those with ALT levels
<10 IU/L, 44.5% with ALT levels 10e19 IU/L, 30.0% with ALT levels 20e39 IU/L, and only
9.5% with ALT levels 40 IU/L. A cumulative hazard function test showed that the higher
the ALT levels, the greater the cumulative incidence rate of diabetes (p < 0.001, log-rank
test). A multiple Cox proportional hazards analysis showed that increasing age, lower educa-
tional levels, higher body mass index levels (25 vs. <25), and higher ALT levels (vs. the refer-
ence group, ALT <10 IU/L), from hazard ratio (HR) Z 1.8, for ALT Z 10e19, HR Z 3.7 for
ALT Z 20e39, to HR Z 4.5 for ALT 40, were significant factors for developing diabetes
(p < 0.001). The hazard ratios of higher ALT levels in the participants without alcohol
consumption were similar to or higher than those in the total cohort.
Conclusion: Higher ALT levels, even within the normal range, are strong predictors of type 2
diabetes independently of body mass index levels with a doseeresponse relationship.
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202 C.-S. Wang et al.Introduction for residents 35 years old since January 1996 because ofType 2 diabetes is an important clinical and public health
problem because of its multiple complications, increasing
mortality rates, and high burden on the health care sys-
tem.1e3 Unfortunately, the prevalence of diabetes in the
world has been increasing. It was estimated that the total
number of people with diabetes was projected to rise from
194 million in 2003 to 333 million in 2025.3 Except for
genetic predisposition, the major causes for the increase of
diabetes are environmental and behavioral changes,
resulting in a sedentary lifestyle and rising body weight.1,3,4
Before the clinical symptoms appear, insulin resistance
might have begun 10 years before the diagnosis of overt
diabetes.2 Inflammatory markers, such as C-reactive
protein, interleukin-6, and tumor necrosis factor-a, are
associated with the development of diabetes.5 Other
biomarkers, such as E-selectin, intercellular adhesion
molecule 1, and vascular cell adhesion molecule 1, are also
type 2 diabetes precursors.6 However, these biomarkers
are not frequently assessed in clinical practice. Therefore,
finding a simple, inexpensive, and frequently usedbiomarker
to predict the development of diabetes is important for
preventing the progression from pre-diabetes to overt
diabetes.
Non-alcoholic fatty liver disease (NAFLD), associated
with type 2 diabetes, causes asymptomatic elevation of
liver enzymes, such as alanine aminotransferase (ALT),
aspartate aminotransferase, and g-glutamyltransferase,
but ALT is most closely associated with fat accumulation in
the liver.7,8 In addition to hepatitis B infection, hepatitis
C infection, heavy smoking, high alcohol consumption, and
hepatotoxic drugs, NAFLD is the most common cause of
elevated ALT levels.7e9 Recently, some studies have
reported that elevated ALT levels are associated with type
2 diabetes,9e13 but others refute that association.14e16
Positive studies were done on high-risk populations, such
as persons with metabolic syndrome,8 obese persons, and
older men.10,12 Some studies show the risk for developing
diabetes is higher only at the top versus the bottom or the
lower three quartiles of elevated ALT levels.10,12,13
Whether there is a doseeresponse relationship between
higher ALT levels, even within the normal range of ALT
levels after adjusting for body mass index (BMI) levels, and
the risk of developing diabetes is not reported. We
screened a community-wide population for hepatitis and
type 2 diabetes from January 1997 through December
2004.17,18 Therefore, our main aim was to use this
community cohort, excluding individuals with viral hepatitis
B and hepatitis C infection, to evaluate the risks of higher
ALT levels, even within the normal range, on the develop-
ment of type 2 diabetes.
Materials and methods
Background description
A-Lein Township, in southern Taiwan’s Kaohsiung County,
has a population of about 31,000. We have been conducting
a population-based and community-wide hepatitis screeningthe township’s high hepatoma mortality rate, which is more
than double that of Taiwan as a whole.17 Intensive health
promotion for hepatitis screening was held before blood
samples, and questionnaires were collected. Villagers, on
their own volition, went to the A-Lein Community Health
center or each village’s community center for screening.
Diabetes screening has been available to adult residents
since the early 1990s because of the increasing prevalence
of type 2 diabetes.18 Until January 1997, we recruited 5467
participants, but excluded 460 because they had diabetes
and 38 because they died before 1997. Those with viral
hepatitis infectiond873 who were anti-HCVþ, 633 who
were HBsAgþ, and 117 who had coinfectionsdwere also
excluded. The remaining 3446 seronegative participants
were prospectively followed for 8 years, from January 1,
1997 through December 31, 2004. Every participant’s dia-
betes status was confirmed before the start of the study;
diabetes was defined according to the 1997 American
Diabetes Association criteria as having fasting blood glucose
126 mg/dL, a nonfasting glucose level 200 mg/dL, or
using hypoglycemic drugs prescribed by a physician before
or at the time of the study. All 3446 participants had their
blood glucose checked at least every other year at the
A-Lein Community Health Center or at other clinics or
hospitals, where their diabetes status was confirmed in
a telephone interview by physicians or trained nurses. Any
participants with impaired glucose tolerancedi.e., a fast-
ing blood glucose level 110 and <126 mg/dL, and casual
blood glucose 140 and <200 mg/dLdwere asked for
a recheck in half a year. The date of diabetes listed in the
statistical analysis was defined as the year that diabetes
was first diagnosed. All the studied participants were anti-
HIV() because there were and still are no anti-HIV(þ)
participants reported in this township. The study was
approved by the Research Committee of the Kaohsiung
County Bureau of Health.
Blood samples were collected and questionnaires
administered during the hepatitis screening. The ques-
tionnaire asked for demographic data, anthropometric
measures, and the specifics of alcohol consumption and
smoking habits. BMI (kg/m2) was computed from weight in
kilograms (with the participant wearing a scrub suit and no
shoes) divided by height in meters squared.
Alcohol consumption was classified as frequent, occa-
sional, or rare or never. For the present study, frequent
alcohol consumption meant consuming an average of
more than one drink (each containing the equivalent of
10 g of pure alcohol) per day during the 6 months before
the interview. Occasional alcohol consumption meant
consuming an average of less than one drink per day.
Smoking was subclassified as 20 cigarettes (1 pack) or more
per day, less than one pack per day, abstained (i.e., quit
smoking at least 6 months before this study), or never
smoked.
Serum samples were sent to the Tainan Blood Center of
the Chinese Blood Service Foundation, Tainan, Taiwan, to
test for HBsAg and anti-HCV markers and ALT levels. ALT
levels were measured using a kinetic ultraviolet (UV) test
for clinical chemistry analyzers (Olympus System Reagent;
Olympus Diagnostica GmbH, Mills, Ireland).
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We compared the trend of the baseline demographic
factors, health behaviors, and different BMI levels at
different ALT levels using a c2 test (ALT level subclassified
as <10, 10e19, 20e39, and 40 U/L according to practical
convenience). A univariate analysis was done to determine
the incidence rate and incidence rate ratio (IRR) of devel-
oping diabetes with various risk factors and different ALT
levels. The person-years of follow-up for each participant
were calculated from the beginning of the study, January
1997, to the year of the diagnosis of diabetes. Participants
who died during the study were censored. Incidence rates
of diabetes were calculated by dividing the number of
incident cases of diabetes by person-years of follow-up.
The NelsoneAalen estimator of cumulative hazard func-
tion and the log-rank test were used to compare the
cumulative incidence of type 2 diabetes between different
ALT levels. Multiple Cox proportional-hazards analysis was
used to estimate the relative risk between different ALT
levels and the development of diabetes for all participants
and the participants without alcohol consumption after
adjusting for demographic factors, health behaviors, and
BMI levels. Hazard ratios (HR) describe the strength of the
association. The data were analyzed using Stata software.
Statistical significance was set at p < 0.05.
Results
The percentage distributions of ALT levels were <10
(40.0%), 10e19 (45.4%), 20e39 (16.5%), and 40 (4.1%)
U/L (Table 1). Those who were younger, male, heavy
smokers, and frequent drinkers of alcohol, and who had
a higher educational level and BMI (25 kg/m2) were
more likely to have higher ALT levels than their coun-
terparts (p < 0.01; c2 test comparing the trend across all
groups).
After 27,068 person-years of follow-up, 337 participants
had developed type 2 diabetes. In the univariate analysis,
participants 50 years old, with <9 years of education and
a BMI of 25, and who frequently drank alcohol had
a higher incidence rate (IR) and IRR for type 2 diabetes than
those without those risk-factor values (p < 0.001) (Table 2).
In the incident cases of diabetes, 37.1% were from those
with a BMI of <25 and 62.9% were from those with a BMI of
25. Among the incident cases, 16.0% were from those
with ALT levels < 10, 44.5% with ALT levels 10e19,
30.0% with ALT levels 20e39, and only 9.5% with ALT levels
40. Compared to participants with ALT levels < 10
(IR Z 0.00576), all others had a higher IR and IRR: ALT
10e19: IRZ 0.01213, IRRZ 2.1; ALT 20e39: IRZ 0.02360,
IRR Z 4.1; and ALT 40: IR Z 0.03049, IRR Z 5.3,
p < 0.001 (Table 2).
The NelsoneAalen cumulative hazard function test
showed that the higher the ALT level, the greater the
cumulative incidence rate of type 2 diabetes (p < 0.001,
log-rank test) (Fig. 1).
A multiple Cox proportional hazards model analysis,
after adjusting for demographic factors, health behaviors,
and BMI, showed that increasing age (subclassified as
35e45, 46e55, 56e65, S66), lower educational levels,higher BMI levels (25 vs. <25) and increasing ALT levels
(vs. the reference group, ALT < 10) were significant
predictors for the development of type 2 diabetes
(p < 0.001). We found a positive doseeresponse relation-
ship for the hazards ratio along with increasing ALT levels
and the development of diabetes: for ALT levels Z 10e19:
HR Z 1.8, 95% confidence interval (CI): 1.3e2.5; for ALT
levels Z 20e39: HR Z 3.7, 95% CI: 2.6e5.12; and for ALT
levels 40: HR Z 4.5, 95% CI: 2.9e7.0 (Table 3). Further
analysis separately conducted in those with BMI 25 and
BMI < 25 also showed that increasing ALT levels were
a significant predictor for the development of diabetes, and
that the higher the ALT levels, the greater the risk. ALT 40
was a very strong predictor for type 2 diabetes in those with
a BMI < 25 (HR Z 7.5, 95% CI: 3.7e15.2). After excluding
723 participants who had frequent or occasional alcohol
consumption, the HR of ALT levels for the development of
diabetes in the participants wihtout alcohol consumption
were similar to or even higher than those in the total cohort
(Table 4).
Discussion
In this community-based cohort study, there were several
important findings. First, 90.5% of the incident type 2 dia-
betes were from those with ALT < 40, but only 9.5% were
from ALT 40. This indicates that the incident cases of
diabetes in persons with so-called normal ALT levels were
considerable. Second, higher ALT levels, even within the
normal ALT range, are independent predictors for the
development of type 2 diabetes, after adjusting for other
major risk factors of diabetes, such as age, gender,
educational level, BMI, smoking, and alcohol consump-
tion.1,4 This finding shows that the risk for developing dia-
betes is higher not only for those with clinically abnormal
ALT levels (i.e., ALT 40), but also for those with ALT levels
in the normal range of 10e39 when compared to those with
ALT levels < 10. In addition, there was a positive dosee
response relationship between increased ALT levels and the
risk of developing diabetes, which means that the higher
the ALT levels, the greater the risk is for developing dia-
betes. Third, the risks of higher ALT levels for incident
diabetes in the participants without alcohol consumption
were similar to or even higher than those in the total
cohort. Fourth, a lower education level is a predictor for
higher incident type 2 diabetes. It might be related with
the lower socioeconomic status, which results in higher
stress, less leisure activity, risky health behaviors, obesity,
poor preventive knowledge and early onset of type 2
diabetes.19
From past studies, elevated (or abnormal) ALT levels are
a predictor for type 2 diabetes.9e12 In the present study,
the risk in persons with higher ALT levels within the normal
range for developing type 2 diabetes was independent of
BMI level (Table 3). In addition, the relative risk for dia-
betes in persons with ALT 10e19 (HR Z 1.8), ALT 20e39
(HRZ 3.7), and ALT 40 (HRZ 4.5) were nearly equal to,
or at least twice as high as, the relative risk in the partic-
ipants with a BMI 25 (HR Z 1.9), which is a well-
documented risk factor for type 2 diabetes. This indicates
that higher ALT levels, even within the clinically normal
Table 1 Trend of baseline characteristics of the community-based seronegative cohort at different ALT levels compared.
ALT levels (U/L)
Participants (%)
(n Z 3446)
<10
(n Z 1171) (34.0%)
10e19
(n Z 1565) (45.4%)
20e39
(n Z 567) (16.5%)
40
(n Z 143) (4.2%)
pa
Age (y)
35e49 1567 (45.5%) 579 (49.5%) 622 (39.7%) 286 (50.4%) 80 (55.9%) <0.0001
50e64 1093 (31.7%) 305 (26.0%) 556 (35.5%) 188 (33.2%) 44 (30.8%)
65 786 (22.8%) 287 (24.5%) 387 (24.7%) 93 (16.4%) 19 (13.3%)
Gender
Male 1456 (42.3%) 345 (29.5%) 712 (45.5%) 327 (57.7%) 72 (50.3%) <0.0001
Female 1990 (57.8%) 826 (70.5%) 853 (54.5%) 240 (42.3%) 71 (49.7%)
Education levels
<9 y 2544 (73.8%) 858 (73.3%) 1193(76.2%) 393 (69.3%) 100 (69.9%) 0.007
9 y 902 (26.2%) 313 (26.7%) 372 (23.8%) 174 (30.7%) 43 (30.1%)
Smoking habit
Yes 645 (18.7%) 165 (14.1%) 302 (19.3%) 148 (26.1%) 30 (21.0%) <0.0001
No 2801 (81.3%) 1006 (85.9%) 1263 (80.7%) 419 (73.9%) 113 (79.0%)
Alcohol consumption
Frequent 169 (4.9%) 31 (2.6%) 76 (4.9%) 48 (8.5%) 14 (9.8%) <0.0001
Occasional 554 (16.1%) 140 (12.0%) 278 (17.8%) 110 (19.4%) 26 (18.2%)
Rare or never 2723(79.0%) 1000 (85.4%) 1211 (77.4%) 409 (72.1%) 103 (72.0%)
BMI (kg/m2)
25 1441 (41.8%) 330 (28.2%) 706 (45.1%) 309 (54.5%) 96 (67.1%) <0.0001
<25 2005 (58.2%) 841 (71.8%) 859 (54.9%) 258 (45.5%) 47 (32.9%)
ALT Z alanine aminotransferase level; BMI Z body mass index.
a The p value refers to a comparison of the trend across the groups using a c2 test.
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the relative risk might be higher than the well-known factor
of BMI 25. This finding is particularly useful for the
prediction or prevention of type 2 diabetes in the era of
epidemic diabetes because most individuals developed
type 2 diabetes with normal ALT levels8; e.g., 90.5% of
the incident diabetes in the present study was in partici-
pants with ALT < 40. This finding provides the evidence
that higher ALT levels within the normal range as well as
abnormal ALT levels are predictors of type 2 diabetes.
Therefore, higher ALT levels, even within the normal range,
represent not only a status of subclinical hepatocellular
inflammation but might also be a pre-diabetic status, which
is associated with the early stage of impaired glucose
regulation and insulin resistance, or is combined with
defects in insulin secretion.20
Although a BMI < 25 is not a major risk factor for type 2
diabetes, 37.1% of the incident diabetes were from those
with a BMI < 25 (Table 2). Moreover, in a multiple Cox
model after adjusting continuous BMI levels, higher ALT
levelsdfrom 10e19, 20e39 to 40d is still a significant
predictor for developing type 2 diabetes in those with
a BMI < 25 as well as a BMI 25 (Table 3). This indicates
that higher ALT levels, even within the normal range, can
be used to predict the incident type 2 diabetes not only in
those with overweight or obesity but also in those with
normal weight. This finding is particularly important in
clinical practice and public health because diabetes
prevention efforts are primarily focused on those who areoverweight and obese, while those with a BMI < 25 are
usually ignored. The cause of the correlation of higher ALT
levels and type 2 diabetes in those with a BMI < 25 is not
well understood, but might be related to a greater waist
circumference, metabolic syndrome, NAFLD,3,21e23 insuffi-
cient physical activity, and heavy alcohol consumption,
or to dietary factors, such as the amount and types of
fat, carbohydrates, and micronutrients consumed.3,4 The
metabolically obese phenotypedi.e., normal body weight
with increased abdominal adipositydis more common in
Asian populations than in their European counterparts given
the same BMI.23 Therefore, drug therapy or lifestyle inter-
vention through moderate weight loss, diet control, and
increased exercise not only decreases the incidence of
diabetes,24 but also reduces intrahepatic fat,25 resolves
steatohepatitis, and lowers ALT levels.25e27
The mechanisms of higher ALT levels within the normal
range and the risk for diabetes are not clear. A higher ALT
level might be a marker of visceral fat deposits in the liver
and thus reflect the status of metabolic fatty liver disease,
and insulin resistance.8 Fat deposits in hepatocytes,
accompanied by ectopic lipid accumulation in other organs,
such as muscles and pancreatic islet cells, might result in
dysregulation of lipid metabolism and insulin resistance.7,9
Hepatic fat content is significantly associated with fasting
plasma insulin concentrations.9,20,25 However, directly
measuring hepatic fat content using proton magnetic
resonance spectroscopy and computed tomography is
unlikely in routine clinical practice.9,10,25 Serum ALT
Table 2 Incidence rate (IR) and incidence rate ratio (IRR) of the risk factors for the development of type 2 diabetes from 1997
to 2004 in A-Lein, Taiwan (n Z 3446).
Incident diabetes (n Z 337) (%) Person-years of follow-up IR IRR (95% CI)
Age
35e49 y 111 (32.9%) 12,066 0.00920 1.0
50e64 y 136 (40.4%) 8087 0.01682 1.8 (1.4e2.4)xx
65 y 90 (26.7%) 5462 0.01648 1.8 (1.3e2.4)xx
Gender
Female 198 (58.8%) 14,937 0.01326 1.0
Male 139 (41.2%) 10,678 0.01302 1.0 (0.8e1.2)
Education level
9 y 50 (14.8%) 6941 0.00720 1.0
<9 y 287 (85.2%) 18,674 0.01537 2.1 (1.6e2.9)xx
Smoking habit
No 269 (79.8%) 20,930 0.01285 1.0
Yes 68 (20.2%) 4685 0.01451 1.1 (0.9e1.5)
Frequent alcohol consumption
Infrequent 311 (92.3%) 24,388 0.01275 1.0
Frequent 26 (7.7%) 1227 0.02119 1.7 (1.1e2.5)x
BMI (kg/m2)
<25 125 (37.1%) 15,097 0.00828 1.0
25 212 (62.9%) 10,518 0.02016 2.4 (1.9e3.1)xx
Alt level (U/L)
<10 54 (16.0%) 8853 0.00610 1.0
10e19 150 (44.5%) 11,708 0.01281 2.1 (1.5e2.9)xx
20e39 101 (30.0%) 4058 0.02489 4.1 (2.9e5.8)xx
40 32 (9.5%) 996 0.03213 5.3 (3.3e8.3)xx
ALT Z alanine aminotransferase level; BMI Z body mass index; CI Z confidence interval; IRR Z incidence risk ratio.
x p < 0.05.
xx p < 0.001.
The cumulative incidence for all participants combined 
Duration (y) 1 2 3 4 5 6 7 8 
ALT <10 5/1171 11/1155 21/1144 25/1133 34/1116 41/1088 50/1068 54/1048 
ALT 10–19 12/1565 31/1545 48/1522 65/1502 87/1476 106/1439 124/1411 150/1369 
ALT 20–39 11/567 27/537 38/537 49/525 65/510 76/491 93/477 101/457 
ALT 40 2/143 9/141 12/134 19/142 26/123 26/116 29/115 32/111 
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Figure 1 NelsoneAalencumulativehazardestimates for incident type2diabetes inacommunity-basedseronegativecohort (nZ3446)
in southern Taiwan for 8 years, from 1997 to 2004, stratified by ALT levels. (Log-rank test for equality of survival functions; p < 0.001).
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Table 3 Multivariate Cox proportional hazards model for incident type 2 diabetes in a community-based seronegative cohort
from 1997 to 2005 in A-Lein, Taiwan.
Risk factors Total cohort (n Z 3446) BMI < 25 (n Z 2005) BMI  25 (n Z 1441)
HR (95% CI) HR (95% CI) HR (95% CI)
Gender (male vs. female) 0.8 (0.6e1.0) 1.0 (0.6e1.5) 0.7 (0.5e1.1)
Age (subclassified: 35e45, 46e55, 56e65, S66) 1.0 (1.0e1.03)xx 1.0 (1.0e1.04)x 1.0 (1.0e1.03)x
Education (<9 vs. 9 y) 1.7 (1.2e2.4)x 2.0 (1.1e3.5)x 1.5 (1.0e2.2)
ALT levels (U/L) (reference group: ALT < 10)
ALT: 10e19 1.8 (1.3e2.5)xx 1.7 (1.1e2.7)x 1.6 (1.03e2.5)x
ALT: 20e39 3.7 (2.6e5.2)xx 2.5 (1.4e4.5)xx 3.6(2.3e5.8)xx
ALT:  40 4.5 (2.9e7.0)xx 7.5(7e15.2)xx 3.0 (1.7e5.5)xx
Smoking (Yes vs. No) 1.2 (0.9e1.7) 1.3 (0.8e2.1) 1.1 (0.7e1.7)
Alcohol consumption (F vs. I)a 1.5 (1.0e2.3) 1.7 (0.9e3.2) 1.2 (0.7e2.1)
BMI (25 vs. <25) (kg/m2) 1.9 (1.6e2.4)xx
BMI (continued) (kg/m2) 1.2 (1.1e1.3)xx 1.1 (1.1e1.2)xx
BMI Z body mass index; CI Z confidence interval; HR Z hazard ratio.
a (F vs. I) Z frequent versus infrequent.
x p < 0.05.
xx p < 0.001.
206 C.-S. Wang et al.appears to be the best indicator of liver fat levels.7,8,20
Elevated ALT levels are also associated with many compo-
nents of insulin resistance syndrome, such as fasting
glucose levels, insulin levels, leptin, adiponectin, triglyc-
erides, cholesterol, and percentage of body fat.12 On the
other hand, a higher ALT level is a marker of subclinical
systemic inflammation and is correlated with increased
oxidative stress and higher hepatic cytokine production,
such as C-reactive protein and tumor necrosis factor-a,
which might contribute to metabolic abnormalities, impair
insulin signaling in the liver and other organs, and increase
the risk for the development of type 2 diabetes.5,9 From
this study, it is implied that the standard of the normal ALT
levels should be lowered in the era of epidemic diabetes,Table 4 Multivariate Cox proportional hazards model for incide
with rare or never alcohol consumption from 1997 to 2005 in A-L
Risk factors Total cohort
HR (95% CI)
Gender (male vs. female) 0.7 (0.5e1.0)
Age (subclassified: 35e45, 46e55, 56e65, S66) 1.02 (1.0e1.0
Education (<9 vs. 9 y) 1.9 (1.2e2.9)
ALT levels (U/L) (reference group: ALT < 10)
ALT: 10e19 1.8 (1.3e2.5)
ALT: 20e39 3.8 (2.6e5.5)
ALT: 40 4.9 (3.0e8.0)
Smoking (Yes vs. No) 1.4 (0.9e2.2)
BMI (25 vs. <25) (kg/m2) 2.0 (1.6e2.6)
BMI (continued) (kg/m2)
BMI Z body mass index; CI Z confidence interval; HR Z hazard ratio
x p < 0.05.
xx p < 0.001.and that the lower the ALT levels, the lower the risk might
be for incident diabetes.Limitations
The present study had several limitations. First, because it
is not primarily a diabetes study, the risk factors for type 2
diabetes, such as family history, diet intake, physical
activity, waist circumference, and cholesterol and triglyc-
eride levels, were not examined. Second, although viral
hepatitis was excluded, medication, hemochromatosis, iron
overload, Wilson’s disease, and other nonhepatic causes
that we did not include in the present study might alsont type 2 diabetes in a community-based seronegative cohort
ein, Taiwan.
(n Z 2723) BMI < 25 (n Z 1617) BMI  25 (n Z 1106)
HR (95% CI) HR (95% CI)
x 0.9 (0.5e1.4) 0.7 (0.4e1.0)
3)x 1.03 (1.0e1.05)x 1.02 (1.0e1.03)x
x 1.8 (0.9e3.4) 1.8 (1.1e3.2)x
xx 1.8 (1.1e3.0)x 1.5 (0.9e2.4)
xx 2.9 (1.5e5.4)xx 3.4 (2.1e5.6)xx
xx 10.1(4.6e22.2)xx 3.1 (1.6e5.8)xx
1.4 (0.7e2.7) 1.4 (0.8e2.6)
xx
1.2 (1.1e1.4)xx 1.1 (1.1e1.2)xx
.
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such conditions might have existed in very few. Third, the
period for blood glucose check, which was conducted every
other year or annually, could not be strictly controlled, but
the delay for diabetes diagnosis might be negligible for
long-term follow-up because of a low incidence rate,
about 1e2% per year, and the participants with glucose
intolerance were called in for a recheck in half a year.
Fourth, the average incidence rate of type 2 diabetes in
this community-based study of seronegative participants is
around 0.013, which was lower than the national average
incidence rate, 0.0249, from the analysis of National Health
Insurance data in 1996.28 Therefore, we urge readers to be
careful when referring to the data about incidence rate.
Conclusion
In this community-based cohort study, higher ALT levelsd
not only in persons with abnormal ALT levels, but also in
those within the normal ALT rangedwere strong predic-
tors for the development of type 2 diabetes independently
of BMI levels. In addition, there was a doseeresponse
relationship between ALT levels and the risk for diabetes.
These findings also provide evidence that ALT level, even
within the normal range, is seemingly a good biomarker
for predicting type 2 diabetes. In addition, the current
clinically normal ALT level, defined for the evaluation of
liver disease, needs to be lowered to increase screenings
for pre-diabetic status when obesity and diabetes are
epidemic.
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